Ventyx Biosciences (VTYX) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

VTYX Stock Forecast

Ventyx Biosciences stock forecast is as follows: an average price target of $33.86 (represents a 1411.61% upside from VTYX’s last price of $2.24) and a rating consensus of 'Buy', based on 8 wall street analysts offering a 1-year stock forecast.

VTYX Price Target

The average price target for Ventyx Biosciences (VTYX) is $33.86 based on 1-year price targets from 8 Wall Street analysts in the past 3 months, with a price target range of $60.00 to $6.00. This represents a potential 1411.61% upside from VTYX's last price of $2.24.

VTYX Analyst Ratings

Buy

According to 8 Wall Street analysts, Ventyx Biosciences's rating consensus is 'Buy'. The analyst rating breakdown for VTYX stock is 0 'Strong Buy' (0.00%), 7 'Buy' (87.50%), 1 'Hold' (12.50%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Ventyx Biosciences Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Jun 13, 2024	Emily Bodnar	H.C. Wainwright	$6.00	$2.98	101.34%	167.86%
Jun 06, 2024	Jeff Jones	Oppenheimer	$10.00	$5.28	89.39%	346.43%
Mar 12, 2024	Derek Archila	Wells Fargo	$16.00	$8.42	90.02%	614.29%
Mar 12, 2024	Jeff Jones	Oppenheimer	$12.00	$8.42	42.52%	435.71%
Dec 19, 2022		Goldman Sachs	$50.00	$32.64	53.19%	2132.14%
Nov 17, 2022	Matthew Harrison	Morgan Stanley	$45.00	$25.43	76.96%	1908.93%
Sep 13, 2022	Michael Yee	Jefferies	$60.00	$38.11	57.44%	2578.57%
May 12, 2022	Yasmeen Rahimi	Piper Sandler	$50.00	$14.53	244.12%	2132.14%

The latest Ventyx Biosciences stock forecast, released on Jun 13, 2024 by Emily Bodnar from H.C. Wainwright, set a price target of $6.00, which represents a 101.34% increase from the stock price at the time of the forecast ($2.98), and a 167.86% increase from VTYX last price ($2.24).

Ventyx Biosciences Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	4
Avg Price Target	-	-	$11.00
Last Closing Price	$2.24	$2.24	$2.24
Upside/Downside	-100.00%	-100.00%	391.07%

In the current month, the average price target of Ventyx Biosciences stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Ventyx Biosciences's last price of $2.24. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 16, 2024	H.C. Wainwright	Neutral	Neutral	Hold
Sep 24, 2024	H.C. Wainwright	Neutral	Neutral	Hold
Jun 13, 2024	H.C. Wainwright	Neutral	Neutral	Hold
Jun 06, 2024	Piper Sandler	Overweight	Overweight	Hold
Jun 06, 2024	Oppenheimer	Outperform	Outperform	Hold
Mar 12, 2024	Wells Fargo		Overweight	Upgrade
Dec 19, 2022	Goldman Sachs		Buy	Initialise
Sep 13, 2022	Needham	Buy	Buy	Hold
Sep 12, 2022	Oppenheimer	Outperform	Outperform	Hold
Sep 12, 2022	Credit Suisse	Outperform	Outperform	Hold
Sep 12, 2022	Jefferies	Buy	Buy	Hold
May 12, 2022	Piper Sandler	Overweight	Overweight	Hold

Ventyx Biosciences's last stock rating was published by H.C. Wainwright on Oct 16, 2024. The company gave VTYX a "Neutral" rating, the same as its previous rate.

Ventyx Biosciences Financial Forecast

Ventyx Biosciences Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Revenue	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	$66.71M	$25.00M	-	-	-	-	-	-	-	-	-
High Forecast	$66.71M	$25.00M	-	-	-	-	-	-	-	-	-
Low Forecast	$66.71M	$25.00M	-	-	-	-	-	-	-	-	-
# Analysts	1	1	-	-	-	-	-	-	-	-	-
Surprise %	-	-	-	-	-	-	-	-	-	-	-

Ventyx Biosciences's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. VTYX's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

Ventyx Biosciences EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	1	1	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	-	-	-	-	-	-	-	-	-	-	-
High Forecast	-	-	-	-	-	-	-	-	-	-	-
Low Forecast	-	-	-	-	-	-	-	-	-	-	-
Surprise %	-	-	-	-	-	-	-	-	-	-	-

undefined analysts predict VTYX's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Ventyx Biosciences's previous annual EBITDA (undefined) of $NaN.

Ventyx Biosciences Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	1	1	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	$7.77M	$-19.79M	$-38.16M	$-38.87M	$-36.04M	$-36.75M	$-35.33M	$-37.63M	$-37.22M	$-36.57M	$-40.83M
High Forecast	$7.77M	$-19.79M	$-38.16M	$-38.87M	$-36.04M	$-36.75M	$-35.33M	$-34.01M	$-32.30M	$-36.57M	$-40.83M
Low Forecast	$7.77M	$-19.79M	$-38.16M	$-38.87M	$-36.04M	$-36.75M	$-35.33M	$-41.97M	$-42.84M	$-36.57M	$-40.83M
Surprise %	-	-	-	-	-	-	-	-	-	-	-

Ventyx Biosciences's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. VTYX's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Ventyx Biosciences SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	1	1	-	-	-	-	-	-	-	-	-
SG&A	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	-	-	-	-	-	-	-	-	-	-	-
High Forecast	-	-	-	-	-	-	-	-	-	-	-
Low Forecast	-	-	-	-	-	-	-	-	-	-	-
Surprise %	-	-	-	-	-	-	-	-	-	-	-

Ventyx Biosciences's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to VTYX last annual SG&A of $NaN (undefined).

Ventyx Biosciences EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	1	1	-	-	-	-	-	-	-	-	-
EPS	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	$0.11	$-0.28	$-0.54	$-0.55	$-0.51	$-0.52	$-0.50	$-0.53	$-0.53	$-0.52	$-0.58
High Forecast	$0.11	$-0.28	$-0.54	$-0.55	$-0.51	$-0.52	$-0.50	$-0.48	$-0.46	$-0.52	$-0.58
Low Forecast	$0.11	$-0.28	$-0.54	$-0.55	$-0.51	$-0.52	$-0.50	$-0.59	$-0.61	$-0.52	$-0.58
Surprise %	-	-	-	-	-	-	-	-	-	-	-

According to undefined Wall Street analysts, Ventyx Biosciences's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to VTYX previous annual EPS of $NaN (undefined).

Ventyx Biosciences Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
VTYX	Ventyx Biosciences	$2.37	$33.86	1328.69%	Buy
GPCR	Structure Therapeutics	$31.48	$99.00	214.49%	Buy
IMCR	Immunocore	$29.40	$70.20	138.78%	Buy
SNDX	Syndax Pharmaceuticals	$13.63	$31.67	132.36%	Buy
IDYA	IDEAYA Biosciences	$26.33	$53.33	102.54%	Buy
PCVX	Vaxcyte	$89.86	$148.80	65.59%	Buy
REPL	Replimune Group	$11.72	$19.00	62.12%	Buy
ASND	Ascendis Pharma	$140.30	$211.14	50.49%	Buy
PTGX	Protagonist Therapeutics	$40.69	$57.33	40.89%	Buy
ACLX	Arcellx	$82.03	$111.60	36.05%	Buy
NUVL	Nuvalent	$88.10	$114.80	30.31%	Buy
TVTX	Travere Therapeutics	$17.14	$21.75	26.90%	Buy
UTHR	United Therapeutics	$379.69	$440.40	15.99%	Buy
VRNA	Verona Pharma	$41.66	$39.50	-5.18%	Buy

VTYX Forecast FAQ

Is Ventyx Biosciences a good buy?

Yes, according to 8 Wall Street analysts, Ventyx Biosciences (VTYX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 7 'Buy' recommendations, accounting for 87.50% of VTYX's total ratings.

What is VTYX's price target?

Ventyx Biosciences (VTYX) average price target is $33.86 with a range of $6 to $60, implying a 1411.61% from its last price of $2.24. The data is based on 8 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Ventyx Biosciences stock go up soon?

According to Wall Street analysts' prediction for VTYX stock, the company can go up by 1411.61% (from the last price of $2.24 to the average price target of $33.86), up by 2578.57% based on the highest stock price target, and up by 167.86% based on the lowest stock price target.

Can Ventyx Biosciences stock reach $3?

VTYX's average twelve months analyst stock price target of $33.86 supports the claim that Ventyx Biosciences can reach $3 in the near future.

What are Ventyx Biosciences's analysts' financial forecasts?

Ventyx Biosciences's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-146M (high $-142M, low $-150M), average SG&A $0 (high $0, low $0), and average EPS is $-2.062 (high $-2.011, low $-2.124). VTYX's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $91.71M (high $91.71M, low $91.71M), average EBITDA is $0 (high $0, low $0), average net income is $-89.041M (high $-89.041M, low $-89.041M), average SG&A $0 (high $0, low $0), and average EPS is $-1.26 (high $-1.26, low $-1.26).